the predictive power of big data in healthcare
TRANSCRIPT
© 2012 IBM Corporation
The predictive power ofBig Data in healthcare
Charlie Schick, PhDBig Data, Healthcare and Life Sciences
© 2011 IBM Corporation2
Industrychallenges
andopportunities
Market Forces Driving Health Care Transformation
Primary Care and Nursingshortages demand workforceproductivity and efficiency
New market entrantsand new approaches tohealth and care deliveryincrease complexity andcompetition
Growing costs fornew, revolutionarytechnologies andtreatments -includingshrinkingreimbursements
Increasing incidence andcost of chronic andre-emerging infectiousdiseases
Health care is shiftingfrom local to state and
national contexts
Changing demographicsand lifestyles drive
associated costs
Empowered consumersexpect better value,
quality, and outcomes
Source: IBM HCLS, IBM GBS Institute for Business Value
© 2011 IBM Corporation3
2009800,000 petabytes
as much Data and ContentOver Coming Decade
44x Business leaders frequentlymake decisions based oninformation they don’t trust, ordon’t have
1 in3
83%of CIOs cited “Businessintelligence and analytics” aspart of their visionary plansto enhance competitiveness
Business leaders say they don’thave access to the informationthey need to do their jobs
1 in2
of CEOs need to do a better jobcapturing and understandinginformation rapidly in order tomake swift business decisions
60%Of world’s datais unstructured
90%
Data trends - volume, velocity, and variety
202035 zettabytes
© 2011 IBM Corporation4
Healthcare data assets
Patient
Finance
PharmacyClaims Health Plans Providers
Adverse EventSupply Chain Lab TestsCharts
SocialDigital Hosp.Research DevicesEMR
© 2012 IBM Corporation
Information Management
© 2011 IBM Corporation6
The future of healthcaretransformation will beDATA-CENTRIC
paraphrasing Ray Campbell, Exec Dir, CEO Mass. Health Data Consortium.
© 2011 IBM Corporation7
Analytics-Driven Healthcare Enterprise
BI Reporting andAd Hoc Analysis
• What happened?• When and where?• How much?
Predictive Analytics
• What will happen?• What will the impact be?
Optimization
• What is the best choice?
• Personalized healthcare• Dynamic fraud detection• Patient, member behavior
• Enterprise analytics• Evidence-based medicine• Clinical outcomes
analytics
• Dashboards• Clinical data repositories• Departmental data marts
• Basic reporting• Spreadsheets
Current analytics level
Data integrationData warehouse
Transactionreporting
Decision supportanalytics
Predictiveanalytics
© 2011 IBM Corporation8
Who needs help?
Providers
Hospitals – non-profit, for-profit,government
Academic medicalcenters
Medical practices
Retail clinics
Ambulatory surgerycenters
Long-term carefacilities
Home healthagencies
Health Insurer/Health Plans Governments
Payers Life Sciences
National healthcaresystems (e.g., England’sNational Health Service)
Government healthinsurance programs(e.g., U.S. Medicare andMedicaid)
Government healthcareagencies (e.g., U.S. HHS,Health Ministries, PublicHealth)
Government-runhospitals
Policy-makers (e.g., theEuropean Union)
Health maintenanceorganizations (e.g., KaiserPermanente)
Blue Cross Blue Shieldplans in the U.S.
Commercial insurers (e.g.,Aetna, BUPA, GroupeMutuel, Wellpoint)
Provider-sponsored plans(e.g., Geisinger HealthCare)
Government-run insuranceprograms
Biotech /Pharmaceuticals(BioPharma)
Academic &Government ResearchLabs
Contract ResearchOrganizations (CROs)
Medical Device &Diagnostics (MD&D)
Medical Distributors,Life Sciences SupportServices, Tools & Tech
© 2011 IBM Corporation9
Big Data solutions accelerate healthcare transformation
Evidence Based Medicine Evidence based Healthcare Models driven by “Health outcomes”. Analyzing Care experience requires inspecting structured and unstructured data
Health Outcomes Provider & Staff shortage demands workforce productivity & Efficiency
improvements Knowing patients 360 implies looking at all their data to provide optimal care
Patient Centered Care Knowing patient’s lifestyle and habits helps drive optimal outcomes and is part of
providing comprehensive care pre and post visit.
Disease Management Conducting disease management and surveillance requires exhaustive
processing of structured and unstructured data to identify chronic and re-emerging infectious diseases
© 2011 IBM Corporation10
Big Data in action
Device analyticsCapturing the vital signs from babies todetect advanced warning of the onset ofcomplications.
Outcomes AnalyticsUnifying all patient related data (structured andunstructured) to get a 360-degree view ofpatient to measure and predict outcomes,manage patient population. And for payer,provider scoring and outcomes-based incentivecalculation.
Genomics AnalyticsCombining patient genomic data with clinical data.Genomic data is becoming critical to the completepatient record, rather than an isolated self-sufficientdata set.
Clinical AnalyticsUnifying clinical, financial, and operations datafor clinical decision support systems,transparency of medical data, aggregating andsynthesizing patient, create the reports they arerequired to create, analyzing their operationaland financial data for efficiency gains.
Fraud Waste and Abuse AnalyticsAnalyzing claims and benefits of OEF/OIFveterans benefits and education fraud. Potential todo this real-time using Streams and Big Insights
Drug discovery analyticsIntegration of clinical, healthcare, patents, medicaljournals, compound info, public research data,safety data to enable contextual, integrated accessto correlated information around disease, target,and compound to provide key insights into decision-making for target selection, compound selection,safety vs. efficacy issue discovery, leadoptimization, clinical issue discovery, and so forth.
© 2011 IBM Corporation11
And now for a deeper dive…
© 2011 IBM Corporation12
OUTCOMES ANALYTICS
© 2011 IBM Corporation13
Who’s Analyzing Outcomes?
© 2011 IBM Corporation14
Who’s Analyzing Outcomes?
© 2011 IBM Corporation15
Who’s Analyzing Outcomes?
© 2011 IBM Corporation16
Who’s Analyzing Outcomes?
© 2011 IBM Corporation17
Who’s Analyzing Outcomes?
© 2011 IBM Corporation18
Who uses what data?
Federal Pharma Payers
EndUsers
Data
All TheBlues!
Payers havetheir ownclaims data.
© 2011 IBM Corporation19
© 2011 IBM Corporation20
© 2011 IBM Corporation21
Disease surveillance
© 2011 IBM Corporation22
Data baby
© 2011 IBM Corporation23
© 2011 IBM Corporation24
© 2011 IBM Corporation25
Personal fitness monitoring - devices
© 2011 IBM Corporation26
Personal fitness monitoring - visualization
© 2011 IBM Corporation27
Personal healthcare analytics?
© 2011 IBM Corporation28
Some of the images are from…
• http://www.plosone.org/article/info:doi%2F10.1371%2Fjournal.pone.0019467
• http://asthmapolis.com/
• dpstyleshttp://www.flickr.com/photos/dpstyles/6862564508/sizes/m/in/photostream/http://www.flickr.com/photos/dpstyles/6976377616/sizes/m/in/photostream/
• http://www.wired.com/gadgetlab/2012/02/first-look-nike-fuelband-exercise-monitor/
• Illustirhttp://www.flickr.com/photos/alper/5669501266/sizes/m/in/photostream/
• dionehinchcliffehttp://www.flickr.com/photos/dionhinchcliffe/6247139118/sizes/m/in/photostream/
• http://www.bodymedia.com/
• https://mybasis.com/
• https://www.insidetracker.com/
• http://www.myzeo.com/
• http://jawbone.com/up/
• http://www.hydracoach.com/
• http://practicefusion.com
• http://patientslikeme.com
© 2011 IBM Corporation29
© 2011 IBM Corporation30
Legal Disclaimer
• © IBM Corporation 2011. All Rights Reserved.• The information contained in this publication is provided for informational purposes only. While efforts were made to verify the completeness and accuracy of the information contained
in this publication, it is provided AS IS without warranty of any kind, express or implied. In addition, this information is based on IBM’s current product plans and strategy, which aresubject to change by IBM without notice. IBM shall not be responsible for any damages arising out of the use of, or otherwise related to, this publication or any other materials. Nothingcontained in this publication is intended to, nor shall have the effect of, creating any warranties or representations from IBM or its suppliers or licensors, or altering the terms andconditions of the applicable license agreement governing the use of IBM software.
• References in this presentation to IBM products, programs, or services do not imply that they will be available in all countries in which IBM operates. Product release dates and/orcapabilities referenced in this presentation may change at any time at IBM’s sole discretion based on market opportunities or other factors, and are not intended to be a commitment tofuture product or feature availability in any way. Nothing contained in these materials is intended to, nor shall have the effect of, stating or implying that any activities undertaken byyou will result in any specific sales, revenue growth or other results.
• If the text contains performance statistics or references to benchmarks, insert the following language; otherwise delete:Performance is based on measurements and projections using standard IBM benchmarks in a controlled environment. The actual throughput or performance that any user willexperience will vary depending upon many factors, including considerations such as the amount of multiprogramming in the user's job stream, the I/O configuration, the storageconfiguration, and the workload processed. Therefore, no assurance can be given that an individual user will achieve results similar to those stated here.
• If the text includes any customer examples, please confirm we have prior written approval from such customer and insert the following language; otherwise delete:All customer examples described are presented as illustrations of how those customers have used IBM products and the results they may have achieved. Actual environmental costsand performance characteristics may vary by customer.
• Please review text for proper trademark attribution of IBM products. At first use, each product name must be the full name and include appropriate trademark symbols (e.g., IBMLotus® Sametime® Unyte™). Subsequent references can drop “IBM” but should include the proper branding (e.g., Lotus Sametime Gateway, or WebSphere Application Server).Please refer to http://www.ibm.com/legal/copytrade.shtml for guidance on which trademarks require the ® or ™ symbol. Do not use abbreviations for IBM product names in yourpresentation. All product names must be used as adjectives rather than nouns. Please list all of the trademarks that you use in your presentation as follows; delete any not included inyour presentation. IBM, the IBM logo, Lotus, Lotus Notes, Notes, Domino, Quickr, Sametime, WebSphere, UC2, PartnerWorld and Lotusphere are trademarks of InternationalBusiness Machines Corporation in the United States, other countries, or both. Unyte is a trademark of WebDialogs, Inc., in the United States, other countries, or both.
• If you reference Adobe® in the text, please mark the first use and include the following; otherwise delete:Adobe, the Adobe logo, PostScript, and the PostScript logo are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States, and/or other countries.
• If you reference Java™ in the text, please mark the first use and include the following; otherwise delete:Java and all Java-based trademarks are trademarks of Sun Microsystems, Inc. in the United States, other countries, or both.
• If you reference Microsoft® and/or Windows® in the text, please mark the first use and include the following, as applicable; otherwise delete:Microsoft and Windows are trademarks of Microsoft Corporation in the United States, other countries, or both.
• If you reference Intel® and/or any of the following Intel products in the text, please mark the first use and include those that you use as follows; otherwise delete:Intel, Intel Centrino, Celeron, Intel Xeon, Intel SpeedStep, Itanium, and Pentium are trademarks or registered trademarks of Intel Corporation or its subsidiaries in the United States andother countries.
• If you reference UNIX® in the text, please mark the first use and include the following; otherwise delete:UNIX is a registered trademark of The Open Group in the United States and other countries.
• If you reference Linux® in your presentation, please mark the first use and include the following; otherwise delete:Linux is a registered trademark of Linus Torvalds in the United States, other countries, or both. Other company, product, or service names may be trademarks or service marks ofothers.
• If the text/graphics include screenshots, no actual IBM employee names may be used (even your own), if your screenshots include fictitious company names (e.g., Renovations, ZetaBank, Acme) please update and insert the following; otherwise delete: All references to [insert fictitious company name] refer to a fictitious company and are used for illustrationpurposes only.